BioNxt Solutions Inc. (OTCMKTS:BNXTF – Get Free Report) was the target of a significant drop in short interest in October. As of October 15th, there was short interest totaling 1,000 shares, a drop of 83.3% from the September 30th total of 6,000 shares. Based on an average daily trading volume, of 11,286 shares, the days-to-cover ratio is presently 0.1 days. Currently, 0.0% of the company’s stock are sold short.
BioNxt Solutions Stock Performance
Shares of OTCMKTS:BNXTF opened at $0.21 on Tuesday. The company has a fifty day simple moving average of $0.24 and a 200 day simple moving average of $0.32. The firm has a market cap of $28.58 million, a PE ratio of -4.20 and a beta of 0.70. BioNxt Solutions has a 12-month low of $0.10 and a 12-month high of $0.79.
BioNxt Solutions (OTCMKTS:BNXTF – Get Free Report) last posted its quarterly earnings data on Friday, August 28th. The company reported ($0.01) EPS for the quarter.
About BioNxt Solutions
BioNxt Solutions Inc is a Canadian life sciences company focused on developing pharmaceutical and diagnostic products using alternative drug-delivery technologies. Its platform work includes orally dissolvable films, transdermal delivery systems and related formulations intended to improve the convenience, dosing and absorption of established medicines.
The company’s development programs have included therapies for neurological and other medical conditions, as well as diagnostic applications.
See Also
- Five stocks we like better than BioNxt Solutions
- Comfort Systems Earnings: AI Slowdown or More Growth Ahead?
- Bristol Myers Squibb’s Cancer Breakthrough Could Have Implications Beyond Its Own Stock
- 5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-Caps
- Anthropic’s IPO Filing Reveals a Massive Opportunity for AI Infrastructure Giants
Receive News & Ratings for BioNxt Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioNxt Solutions and related companies with MarketBeat.com's FREE daily email newsletter.
